All these observations strongly support the fact that impaired glucose homeostasis in AD patients seems to be closely related to brain (hypothalamic) damage due to local IR (abnormal insulin signaling), thus augmenting brain TNF-α production and probably perpetuating neuroinflammation (Figure 4). Here, TNF is linked to Alzheimer disease.